SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.
about
The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptinA prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptomsSymptom-based outcome measures for dyspepsia and GERD trials: a systematic review.Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.Functional dyspepsia.Health-related quality of life and gastrointestinal disease.Diabetic gastropathy and prokinetics.Health-related quality of life in functional dyspepsia.Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial.Patient assessment of treatment satisfaction: methods and practical issuesThe effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.Modified Severity of Dyspepsia Assessment pain scale: a new tool for measuring upper abdominal pain in osteoarthritis patients taking NSAIDsProton pump inhibitors for functional dyspepsia.Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study.Translation and psychometric evaluation of the Chinese version of functional digestive disorders quality of life questionnaire.Review article: endpoints used in functional dyspepsia drug therapy trials.Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy.Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials
P2860
Q21261893-D666F49A-F257-4139-B85F-ECAEDE187984Q30891703-E84204C8-846C-42E1-93FF-59E490A124EBQ33211134-2420E3A6-E52E-427E-9AE0-41C1CCCF96A0Q33887129-A3F35A91-1031-4CA5-8263-9503EB88383DQ34409166-88D5FC64-2054-42CC-B8D1-805C0D3BB8E5Q34631350-8592AD30-C17B-49DA-82EB-C07D1E5B53CDQ35068007-CDBA8778-2ADD-4F2E-A7FA-7DAAEAECD381Q35206703-0FD56775-C0C6-4728-B97F-051DC1407F92Q35597101-DFDFA919-337B-4A39-B4C1-B8EF5A38B644Q35745046-C186E66A-F002-4C0D-B069-99AD91A00D2EQ35828322-C55F91FE-524F-496D-9A36-7EE93BEF81D6Q36160651-00CEC6A3-65B7-4FB1-8986-4C43E8408150Q36300366-AFC15E80-009D-4A13-993E-E42C2BEA00DDQ36511761-3F8AC0B4-D6D7-4149-8DDB-0A1AFA7DD57CQ37583115-976D1C59-411E-4CB3-9D99-AD5A57CBA747Q37827564-7A7DA7EE-1BE7-44DB-B791-888BD9B5F488Q39349036-5E9A2F22-1EEA-45A8-B9AD-3B196AD7460BQ40664359-14F7401E-0763-44D5-AECA-06607391F77BQ43650462-1A9998AA-BFC0-4BC5-B606-44226F1490C2Q43944829-B3AA87D1-50AE-4CEE-86BB-5305B4803AEBQ44255876-34E55BCE-9D57-4788-8B3C-423BEF36932DQ46447275-F9B0822B-E4A7-4C2B-8D81-D46CF0F27C7FQ51947880-403B7F41-DCFB-4598-8AF8-4C1A75BE97B1Q58139133-5F673FDB-9851-4B73-A084-E04E5810AB71
P2860
SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
SODA (severity of dyspepsia as ...... for dyspepsia-related health.
@en
SODA
@nl
type
label
SODA (severity of dyspepsia as ...... for dyspepsia-related health.
@en
SODA
@nl
prefLabel
SODA (severity of dyspepsia as ...... for dyspepsia-related health.
@en
SODA
@nl
P2093
P1476
SODA (severity of dyspepsia as ...... for dyspepsia-related health.
@en
P2093
P304
P356
10.1016/S0895-4356(00)00365-6
P577
2001-08-01T00:00:00Z